Parkinson s Disease
13
7
7
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
7.7%
1 terminated out of 13 trials
75.0%
-11.6% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (13)
The Efficacy and Safety of Temporal Interference Stimulation on Motor Symptoms of Parkinson's Disease
Primary Parkinsonian Pain: Clinical Association and Phenotype
Which Tools Better Predict Fall Risk in Parkinson's Disease: A Comparative Study of Objective, Self-Reported, and Functional Balance Assessment
Virtual Reality Verses Conventional Physical Therapy in Parkinson's Disease Patients
Cognitive-Based Balance Rehabilitation in Parkinson's Disease: Virtual Reality vs. Dual Task
Comparison of Immersive and Non-Immersive Virtual Reality Rehabilitation in Parkinson's Disease
Effects of Accelerated rTMS On Motor and Cognitive Function in Parkinson's Disease
D-SPARK: A Clinical Trial of D-Serine for Modifying Parkinson's Disease Progression
Trunk Control Exercises and Mirror Therapy on Balance and Posture in Parkinson's Disease
Colonic Tissue Biopsy Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis or REM Sleep Behavior Disorder
Rhythmic Auditory Stimulaton Using Personalized Music Therapy in Parkinson's Disease
MRgFUS for Parkinson's Tremor
Genetics of Motor Learning